Volume 21 (2022)
Volume 20 (2021)
Volume 19 (2020)
Volume 18 (2019)
Volume 17 (2018)
Volume 16 (2017)
Volume 15 (2016)
Volume 14 (2015)
Volume 13 (2014)
Volume 12 (2013)
Volume 11 (2012)
Volume 10 (2011)
Number of Volumes 13
Number of Issues 47
Number of Articles 517
Number of Contributors 1,669

- We would like to inform you about the title of our journal, which has previously been entitled "Iranian Journal of Neurology". 
- The new title is Current Journal of Neurology. The changes are effective as of  Vo. 19, No. 1.

- The Current Journal of Neurology is dedicated to the Iranian Neurological Association.

- The Journal is a peer-reviewed journal published quarterly and publishes neurological experiences in basic or clinical fields.

- The Current Journal of Neurology aims to publish manuscripts of a high scientific quality representing original clinical, diagnostic or experimental works or observations in neurological sciences. Papers in English are welcomed, particularly those which bring novel information and research in clinical or basic fields from the neurological disorders. All received manuscripts coving the scope of the journal will be evaluated by properly competent referees.

- This Journal Indexed in Scopus, PubMed, PubMed Central, ESCI (Web of Science), Academic Keys, Ebsco, Electronic Journals Library, Google Scholar, InfoBase Index, Islamic World Science Citation Center (ISC), LocatorPlus, Scientific Information Database (SID), Ulrichsweb Global Serials Directory, WorldCat.

Original Article
Iranian specialists’ approach to treatment escalation in multiple sclerosis patients with cognitive impairment

Fereshteh Ghadiri; Elnaz Asadollahzadeh; Zahra Ebadi; Mohammad Ali Sahraian; Amirreza Azimi; Samira Navardi; Hora Heidari; Zohreh Abna; Marzieh Aboutorabi; Iman Adibi; Seyed Mohammad Baghbanian; Sepideh Paybast; Maryam Poursadeghfard; Samaneh Hosseini; Sareh Shahmohammadi; Mehran Ghaffari; Hamidreza Ghalyanchi-Langroodi; Masoud Ghiasian; Hoda Kamali; Ebrahim Kouchaki; Farzad Mehrabi; Ehsan Mohammadianinejad; Mohammad Ali Nahayati; Abdorreza Naser Moghadasi

Volume 22, Issue 1 , January 2023, Pages 1-7

Abstract
  Background: People with multiple sclerosis ‎(MS) and their physicians recognize cognitive retention as an important desired outcome of disease-modifying therapies (DMTs). In this study, we attempted to gather the opinions of Iranian MS experts regarding the treatment approach toward clinical ...  Read More

Original Article
Comparison of side effects of the dose-1 of AstraZeneca and Sinopharm vaccines in patients with multiple sclerosis in Kermanshah, Iran (2021)

Nazanin Razazian; Mohammad Ali Sahraian; Mansour Rezaei; Sharareh Eskandarieh; Kianoosh Khamoushian; Seyede Elham Mousavi; Negin Fakhri

Volume 22, Issue 1 , January 2023, Pages 8-15

Abstract
  Background: Coronavirus 2019 (COVID-19) vaccination is recommended for people with multiple sclerosis (MS). This study evaluated the side effects of Sinopharm and AstraZeneca vaccines in MS patients.Methods: In this cross-sectional study among MS patients in Kermanshah province, Iran, who received Sinopharm ...  Read More

Original Article
Challenges of patients with multiple sclerosis in receiving health care services in Iran

Niloofar Jahromi; Sharareh Eskandarieh; Nazanin Maleki; Narges Sistany-Allahabadi; Mohammad Ali Sahraian

Volume 22, Issue 1 , January 2023, Pages 16-22

Abstract
  Background: Multiple sclerosis (MS) is a debilitating, non-traumatic, neurological disorder in young adults and can reduce quality of life (QoL) by interfering with the ability to work, leisure activities, and routine living tasks. Various studies have shown the dissatisfaction of people with MS in different ...  Read More

Original Article
The effect of body mass index on the morbidity and outcomes of COVID-19 in Iranian patients with multiple sclerosis

Nasim Rezaeimanesh; Naghmeh Abbasi; Mohammad Ali Sahraian; Amirreza Azimi; Soodeh Razeghi-Jahromi; Abdorreza Naser Moghadasi

Volume 22, Issue 1 , January 2023, Pages 23-29

Abstract
  Background: It seems that patients with multiple sclerosis (MS) are at a higher risk for coronavirus disease 2019 (COVID-19) implications due to being subjected to immunomodulatory or immunosuppressive treatments. Besides, obesity as a risk factor may lead to more adverse consequences. The relationship ...  Read More

Original Article
The association of serum carnitine levels with severity of fatigue in patients with multiple sclerosis: A pilot study

Mohammad Hossein Harirchian; Siavash Babaie; Nika Keshtkaran; Sama Bitarafan

Volume 22, Issue 1 , January 2023, Pages 30-34

Abstract
  Background: Fatigue is a common complaint of patients with multiple sclerosis (MS), adversely affecting their quality of life. There is a lot of evidence showing that carnitine deficiency is linked to fatigue development and severity in some conditions. This study aimed to evaluate the association between ...  Read More

Original Article
Stability monitoring of patients with myasthenia gravis using a mobile-based application

Emad Alaei Tafti; Marjan Ghazisaeedi; Payam Sarraf

Volume 22, Issue 1 , January 2023, Pages 35-43

Abstract
  Background: Failure in early diagnosis of myasthenia gravis (MG) and the risks of taking certain medications and undergoing surgery and anesthesia can lead to severe respiratory disorders and death. However, there are therapeutic measures that significantly control the disease and improve individual’s ...  Read More

Original Article
Association analysis of serotonin transporter gene polymorphism among the South-Indian migraineurs

Pallavi Kesavan; Aiswarya Padmaja Satheesh; Akram Husain Rehman Syed Rasheed; Umamaheshwari Veerappan; Subramaniyan Kannaian; Ramakrishnan Veerabathiran

Volume 22, Issue 1 , January 2023, Pages 44-49

Abstract
  Background: Migraine is a multifactorial neurological disorder characterized by frequent moderate to severe intensity headaches. The genetic variations in synaptic and post-receptor signalling proteins have direct effect on the process of serotonergic neurotransmission.Methods: We aimed to investigate ...  Read More

Review Article
The relationship between retinal layer thickness and cognition in patients with multiple sclerosis: A systematic review of current literature

Abdorreza Naser Moghadasi; Omid Mirmosayyeb; Narges Ebrahimi; Mohammad Ali Sahraian; Aida Mohammadi; Mahsa Ghajarzadeh

Volume 22, Issue 1 , January 2023, Pages 50-57

Abstract
  Background: This study was conducted to evaluate the relationship between retinal layer thickness (RLT) and cognition in patients with multiple sclerosis (MS).Methods: We searched PubMed, Scopus, Embase, Web of Science, and Google Scholar. The search strategy included the MeSH and text words as [“ora ...  Read More

Short Communication
A nomogram-based clinical tool for acute ischemic stroke screening in prehospital setting

Alireza Baratloo; Mahtab Ramezani; Hosein Rafiemanesh; Meisam Sharifi; Somayeh Karimi

Volume 22, Issue 1 , January 2023, Pages 58-62

Abstract
  Background: We believe that designing a new tool which is comparable in terms of both sensitivity and specificity may play an important role in rapid and more accurate diagnosis of acute ischemic stroke (AIS) in prehospital stage. Therefore, we intended to develop a new clinical tool for the diagnosis ...  Read More

Guillain-Barre syndrome in patients with coronavirus disease-2019: Report of six cases and review of literature

Ali Asghar Okhovat; Behnaz Ansari; Helia Hemasian; Bahram Haghi-Ashtiani; Soroor Advani; Bentolhoda Ziaadini; Siamak Abdi; Hajir Sikaroudi; Shahriar Nafissi; Farzad Fatehi

Volume 19, Issue 3 , July 2020, , Pages 122-130

https://doi.org/10.18502/cjn.v19i3.5425

Abstract
  Background: Few studies have reported the association of Guillain-Barre syndrome (GBS) and coronavirus disease-2019 (COVID-19) infection. In this study, we reported GBS in six patients infected with COVID-19 and reviewed all existing literature about GBS in association with COVID-19. Methods: This study ...  Read More

Assessment of computed tomography perfusion RAPID estimated core volume accuracy in patients following thrombectomy

Riwaj Bhagat; Allison Muha; Kerri Remmel; Wei Liu

Volume 21, Issue 1 , January 2022, , Pages 17-22

https://doi.org/10.18502/cjn.v21i1.9356

Abstract
  Background: Computed Tomography Perfusion (CTP) maps ischemic core volume (CV) and penumbra following a stroke; however, its accuracy in early symptom onset is not well studied. We compared the accuracy of CTP RAPID estimated CV with diffusion weighted imaging (DWI) infarct volume (IV) in patients following ...  Read More

Effect of energy conservation strategies on fatigue, function, and quality of life in adults with motor neuron disease: Randomized controlled trial

Hamid Reza Fateh; Reihaneh Askary-Kachoosangy; Niloofar Shirzad; Alireza Akbarzadeh-Baghban; Farzad Fatehi

Volume 21, Issue 2 , April 2022, , Pages 83-90

https://doi.org/10.18502/cjn.v21i2.10491

Abstract
  Background: Fatigue is one of the most frequent complaints in patients with motor neuron diseases (MNDs), with a significant impact on the quality of life (QOL). Current pharmacological or non-pharmacological treatments of fatigue in this population lack enough evidence to be applied in the clinical ...  Read More

B vitamins and their combination could reduce migraine headaches: A randomized double-blind controlled trial

Shiva Nematgorgani; Soodeh Razeghi-Jahromi; Elham Jafari; Mansoureh Togha; Pegah Rafiee; Zeinab Ghorbani; Zeynab Sadat Ahmadi; Vali Baigi

Volume 21, Issue 2 , April 2022, , Pages 105-118

https://doi.org/10.18502/cjn.v21i2.10494

Abstract
  Background: The B vitamins can potentially help prevent migraine. This study was designed to examine the effects of supplementation with thiamine (B1), pyridoxine (B6), cobalamin (B12), folic acid (B9), and a combination of these vitamins on women with episodic migraine (EM).Methods: This study was a ...  Read More

A randomized controlled trial investigating the effects of a mediterranean-like diet in patients with multiple sclerosis-associated cognitive impairments and fatigue

Soodeh Razeghi-Jahromi; Rozita Doosti; Zeinab Ghorbani; Roghayyeh Saeedi; Maryam Abolhasani; Naeemeh Akbari; Fatemeh Cheraghi-Serkani; Abdorreza Naser Moghadasi; Amirreza Azimi; Mansoureh Togha; Mohammad Ali Sahraian

Volume 19, Issue 3 , July 2020, , Pages 112-121

https://doi.org/10.18502/cjn.v19i3.5424

Abstract
  Background: Among multiple sclerosis (MS) related symptoms and complications, fatigue might impact roughly 90% of patients. Decline in cognitive function is one of the other complications that occur in the first years after disease onset. The Mediterranean diet is one of the well-known anti-inflammatory ...  Read More

Original Article
Factors associated with the number of months of delaying in multiple sclerosis diagnosis: Comparison of count regression models

Abolfazl Hosseinnataj; Roya Nikbakht; Seyed Nouraddin Mousavinasab; Sharareh Eskandarieh; Mohammad Ali Sahraian; Seyed Mohammad Baghbanian

Articles in Press, Accepted Manuscript, Available Online from 26 March 2023

Abstract
  Background: It may take a long time to diagnose multiple sclerosis (MS) since the emergence of primary symptoms. This study aimed to use count regression models to compare their fit and to identify factors affecting delay in the diagnosis of MS.Methods: Data were collected from the Nationwide MS Registry ...  Read More

Original Article
Waterpipe and cigarette smoking and drug and alcohol consumption, and the risk of primary progressive multiple sclerosis: A population-based case-control study

Seyyed Hosein Mortazavi; Abdorreza Naser Moghadasi; Amir Almasi-Hashiani; Mohammad Ali Sahraian; Hooman Goudarzi; Sharareh Eskandarieh

Articles in Press, Accepted Manuscript, Available Online from 03 April 2023

Abstract
  Background: Multiple sclerosis (MS) is a chronic central nervous system disease, and primary progressive multiple sclerosis (PPMS) is one the main types of MS, which has unknown environmental risk factors.   The present study was conducted with the aim to identify the association of waterpipe and ...  Read More

Original Article
Fear of re-infection, relapse, and anxiety during COVID-19 pandemic in patients with multiple sclerosis: A multi-center study

Abdorreza Naser Moghadasi; Saeed Vaheb; Sara Hamtaei-Ghashti; Aysa Shaygannejad; Mozhdeh Askari; Vahid Shaygannejad; Mohmmad Ali Sahraian; Mahsa Ghajarzadeh

Articles in Press, Accepted Manuscript, Available Online from 18 March 2023

Abstract
  Background: Fear of relapse and re-infection during the coronavirus disease 2019 (COVID-19) pandemic can affect people with chronic relapsing diseases, such as multiple sclerosis (MS). We evaluated fear of re-infection, anxiety, and relapse during the COVID-19 pandemic in Iranian people with MS.Methods: ...  Read More

Original Article
Association of dietary patterns with migraine: A matched case-control study

Fahimeh Martami; Mansoureh Togha; Mostafa Qorbani; Donya Shahamati; Zhaleh Salami; Sakineh Shab-Bidar

Articles in Press, Accepted Manuscript, Available Online from 09 April 2023

Abstract
  Background: Little is known about the association between dietary patterns and odds of migraine. We aimed to investigate the association between posteriori dietary patterns and migraine odds and migraine-related outcomes using principal component analysis (PCA).Methods: A total of 500 participants enrolled ...  Read More

Original Article
Iranian specialists’ approach to surgery in patients with multiple sclerosis

Fereshteh Ghadiri; Zahra Ebadi; Elnaz Asadollahzadeh; Mohammad Ali Sahraian; Amirreza Azimi; Samira Navardi; Hora Heidari; Zohreh Abna; Marzieh Aboutorabi; Iman Adibi; Seyed Mohammad Baghbanian; Sepideh Paybast; Maryam Poursadeghfard; Samaneh Hosseini; Sareh Shahmohammadi; Mehran Ghaffari; Hamidreza Ghalyanchi-Langroodi; Masoud Ghiasian; Hoda Kamali; Ebrahim Kouchaki; Farzad Mehrabi; Ehsan Mohammadianinejad; Mohammad Ali Nahayati; Abdorreza Naser Moghadasi

Articles in Press, Accepted Manuscript, Available Online from 10 April 2023

Abstract
  Background: Data on perioperative risk stratification in patients with multiple sclerosis (MS) are limited. In this regard, the present study was conducted to investigate Iranian specialists’ approach to surgical counseling for patients with MS (PwMS).Methods: 21 MS specialists were asked about ...  Read More

Original Article
Epidemiological parameters of multiple sclerosis in Chaharmahal and Bakhtiari Province, Iran

Mohammad Amin Omrani; Asghar Bayati; Mohammad Ali Sahraian; Sharareh Eskandarieh

Articles in Press, Accepted Manuscript, Available Online from 16 April 2023

Abstract
  Background: Multiple sclerosis (MS) is a neurological disease with a high burden and disability. There are reports of various medications’ side effects on patients with MS. The aim of the study is to determine the characteristics and medicine usage distribution among patients with MS in Chaharmahal ...  Read More

Review Article
Alternate dosing of fingolimod in relapsing-remitting multiple sclerosis: A systematic review

Fereshteh Ghadiri; Omid Mirmosayyeb; Mohammad Ali Sahraian; Abdorreza Naser Moghadasi; Mahsa Ghajarzadeh

Articles in Press, Accepted Manuscript, Available Online from 13 March 2023

Abstract
  Background: Fingolimod is approved in relapsing-remitting multiple sclerosis (RRMS) with the recommended dose of 0.5 mg daily. To tackle possible adverse events, some clinicians may reduce the dose of fingolimod, mainly in the alternate-day form. We systematically reviewed the literature for efficacy ...  Read More

Review Article
Adverse side effects of Glatiramer acetate and Interferon beta-1a in patients with multiple sclerosis: A systematic review of case reports

Mohsen Rastkar; Mahsa Ghajarzadeh; Mohammad Ali Sahraian

Articles in Press, Accepted Manuscript, Available Online from 11 May 2023

Abstract
  Background: Glatiramer acetate (GA) and Interferon (IFN) beta-1a are used as first-line disease-modifying treatments for multiple sclerosis (MS). In this systematic review, we summarized case reports and case series of adverse side effects of GA and IFN beta-1a in MS patients.Methods: Without any restrictions, ...  Read More

Publisher:
Tehran University of Medical Sciences

Director-in-Charge:
Mahmood Motemedi

Editor-in-Chief:
Shahriar Nafissi, M.D,

Deputy Editor:
Farzad Fatehi, M.D,

Editorial Board:
Shahram Attarian, M.D, P.h.D


Frequency: Quarterly

Online ISSN: 2717-011X

COPE

This journal is a member of, and subscribes to the principles of, the Committee on Publication Ethics (COPE).

iThenticate: Plagiarism Detection Software

Each manuscript published in the Current Journal of Neurology will be checked by iThenticate.

Keywords Cloud